NYSE: AGE - AgeX Therapeutics, Inc.

Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção AgeX Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease.

mais detalhes
Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2018-11-29
ISIN US00848H1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.agexinc.com
Цена ао 11.1
Alteração de preço por dia: 0% (11.1)
Alteração de preço por semana: 0% (11.1)
Alteração de preço por mês: 0% (11.1)
Alteração de preço em 3 meses: 0% (11.1)
Mudança de preço em seis meses: 0% (11.1)
Mudança de preço por ano: -50.27% (22.32)
Mudança de preço em 3 anos: +1 508.7% (0.69)
Mudança de preço em 5 anos: +692.86% (1.4)
Mudança de preço desde o início do ano: 0% (11.1)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.98 6
P/BV 0.079 10
P/E 0 0
EV/EBITDA -0.4521 0
Total: 5.13

Eficiência

Nome Significado Nota
ROA, % -123.72 0
ROE, % -270.67 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.4441 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -91.65 0
Rentabilidade Ebitda, % -15.27 0
Rentabilidade EPS, % 4028.55 10
Total: 2.6
Mais detalhes

Instituições Volume Compartilhar, %
Broadwood Capital, Inc. 2997156 7.9
Vanguard Group Inc 701755 1.85
Sigma Planning Corp 286425 0.75
Prescott General Partners LLC 185185 0.49
Bridgeway Capital Management, Inc. 144770 0.38
Geode Capital Management, LLC 140994 0.37
Blackrock Inc. 124301 0.33
Strategic Wealth Investment Group, LLC 97375 0.26
Creative Planning 70700 0.19
Northern Trust Corporation 31533 0.08

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Sprott Uranium Miners ETF 0.42828 343.52 3.27507
Global X Uranium ETF 0.21695 7.84 1.74266
0.33175.682.51



Supervisor Cargo Pagamento Ano de nascimento
Ms. Eun-Jae Park CPA Chief Financial Officer 295.29k 1972 (53 ano)
Dr. Ivan Labat Chief Information Officer N/A
Ms. Judith Segall Secretary N/A 1953 (72 ano)

Endereço: United States, Alameda. CA, 1101 Marina Village Parkway - abrir no Google Maps, abrir mapas Yandex
Site: https://www.agexinc.com